7th Treg-Directed Therapies Summit

March 25 - 27, 2025 - MA US

Hanson Wade

info@hansonwade.com
Phone:0000000000

Over the past year, the Treg sector has seen groundbreaking investments and strategic collaborations between leading biotech and pharma companies like Quell and AstraZeneca, and Parvus and AbbVie, creating a surge of innovation and spotlighting Treg cell therapies and modulators as the next frontier in autoimmune and inflammatory disease treatments. Tregs hold the potential to revolutionize care for conditions that have long lacked effective solutions and are the future of precision medicine in autoimmune and inflammatory diseases. Time: 8:00 AM - 5:00 PM

More Information